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Arsenic resistance in Synechocystis sp. strain PCC 6803 is mediated by an operon of three genes in which arsC
codes for an arsenate reductase with unique characteristics. Here we describe the identification of two
additional and nearly identical genes coding for arsenate reductases in Synechocystis sp. strain PCC 6803,
which we have designed arsI1 and arsI2, and the biochemical characterization of both ArsC (arsenate reduc-
tase) and ArsI. Functional analysis of single, double, and triple mutants shows that both ArsI enzymes are
active arsenate reductases but that their roles in arsenate resistance are essential only in the absence of ArsC.
Based on its biochemical properties, ArsC belongs to a family that, though related to thioredoxin-dependent
arsenate reductases, uses the glutathione/glutaredoxin system for reduction, whereas ArsI belongs to the
previously known glutaredoxin-dependent family. We have also analyzed the role in arsenate resistance of the
three glutaredoxins present in Synechocystis sp. strain PCC 6803 both in vitro and in vivo. Only the dithiolic
glutaredoxins, GrxA (glutaredoxin A) and GrxB (glutaredoxin B), are able to donate electrons to both types of
reductases in vitro, while GrxC (glutaredoxin C), a monothiolic glutaredoxin, is unable to donate electrons to
either type. Analysis of glutaredoxin mutant strains revealed that only those lacking the grxA gene have
impaired arsenic resistance.
Arsenic is a ubiquitous pollutant that can produce cancer
and cause serious health problems in certain parts of the world
(36). Because of the wide distribution of arsenic compounds,
arsenic resistance is widespread among living organisms (47).
Most resistance systems reduce arsenate to arsenite and export
the latter to the outside of the cell or transport it to a vacuole
(31). Arsenate reduction to arsenite is catalyzed by arsenate
reductase, an enzyme at least three families of which have been
described (25, 30, 43). The first family is exemplified by Esch-
erichia coli ArsC, a protein that uses the glutathione (GSH)/
glutaredoxin system as a reducing system and has a single
catalytic cysteine. The second family is represented by Staph-
ylococcus aureus and Bacillus subtilis arsenate reductases (also
named ArsC). These enzymes are related to low-molecular-
weight protein phosphotyrosine phosphatases and use thiore-
doxin as a reducing system through an intramolecular redox
cascade requiring three cysteines for arsenate reduction (25).
The last family is present only in eukaryotic organisms and was
initially described in Saccharomyces cerevisae and, more re-
cently in Leishmania major and Arabidopsis thaliana (6, 32, 53).
These arsenate reductases also use the GSH/glutaredoxin sys-
tem as a reductant, but they are related not to the E. coli
reductase but rather to the Cdc25 family of protein phos-
phatases.
Arsenic resistance in Synechocystis sp. strain PCC 6803 is
mediated by an operon of three genes that is regulated by an
unlinked arsR homolog. The operon includes an arsenite trans-
porter gene, arsB; an arsH homolog without a clear function in
arsenic resistance; and an arsenate reductase gene, arsC (23),
whose product is referred to below as ArsCsyn. ArsCsyn belongs
to a new type of hybrid arsenate reductases that, though re-
lated to thioredoxin-dependent arsenate reductases, use the
GSH/glutaredoxin system for reduction (19).
Glutaredoxins are small proteins first discovered as electron
donors for ribonucleotide reductase but subsequently shown to
be able to reduce other proteins, such as S-phosphoadenosyl-
sulfate reductase and arsenate reductase. They are also able to
reduce mixed disulfides between proteins and GSH (10). Two
families of glutaredoxins have been described: dithiolic glu-
taredoxins (which have two cysteines in their catalytic site) and
monothiolic glutaredoxins (which only have one cysteine in
their catalytic site). To date, despite extensive biochemical
characterization of different glutaredoxin isoforms from plants
(44), little is known about glutaredoxin function in photosyn-
thetic organisms, although recent biochemical approaches
have shed some light (2, 17, 18, 38, 52).
Here we report the identification of two additional and
nearly identical genes coding for arsenate reductases. We have
designated them arsI1 and arsI2, because these two genes code
for identical proteins belonging to the E. coli family of arsenate
reductases. They are shown to play secondary roles in arsenate
resistance in Synechocystis, since deletion of either of these
genes has an effect only in combination with the absence of
arsC. We have also performed biochemical characterization of
the ArsCsyn and ArsI proteins and have found that both pro-
teins have glutaredoxin-dependent arsenate reductase activity.
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Since both proteins are capable of using the GSH/glutaredoxin
system, we have studied the role of this system in arsenate
reduction. Synechocystis sp. strain PCC 6803 contains three
genes encoding glutaredoxins. Two of these genes code for
prokaryotic dithiolic glutaredoxins, while the third codes for a
monothiolic glutaredoxin. In this study we have analyzed the
roles of these glutaredoxins in arsenate resistance and have
found that only one of the dithiolic glutaredoxins, GrxA, is
essential in vivo. Nevertheless, both of the dithiolic enzymes
are active in the arsenate reductase reaction in vitro.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Synechocystis sp. strain PCC 6803 was
grown photoautotrophically at 30°C in BG11 medium supplemented with 1 g per
liter of HCO3Na (BG11C) (40) and bubbled with a continuous stream of 1%
(vol/vol) CO2 in air under continuous fluorescent illumination (50 mol of
photons per m2 per s; white light). For plate cultures, BG11C liquid medium was
supplemented with 1% (wt/vol) agar. Antibiotics were added to final concentra-
tions of 50 to 200 g/ml for kanamycin, 20 to 40 g/ml for chloramphenicol, or
2 to 10 g/ml for spectinomycin when required. BG11C medium was supple-
mented with different concentrations of Na2HAsO4 in the presence or the ab-
sence of phosphate at the standard concentration as indicated for BG11C.
Escherichia coli DH5 (Bethesda Research Laboratories) grown in Luria-
Bertani medium as described in reference 45 was used for plasmid construction
and replication. E. coli BL21(DE3) and E. coli XL1-Blue grown in Luria-Bertani
medium or Luria-Bertani medium supplemented with 2% glucose, respectively,
were used for protein expression. E. coli cultures were supplemented with 100
g/ml ampicillin, 40 g/ml chloramphenicol, 50 g/ml kanamycin, or 100 g/ml
spectinomicyn when required.
Insertional mutagenesis of Synechocystis genes. All the oligonucleotides used
for cloning and insertional or site-directed mutagenesis are described in Table S1
in the supplemental material. For the sll5104 and slr6037 insertional mutants, a
1,063-bp PCR fragment was amplified from total genomic DNA using oligonu-
cleotides ARSI1 and ARSI2 and was cloned into pGEMT to generate pARSI1.
Then an Sp (39) or C.C1 (8) cassette was inserted into a PflMI site in the arsI1
and arsI2 open reading frames (ORFs), generating pARSI2 and pARSI4, re-
spectively. For double mutant construction, a 970-bp DNA fragment lacking the
slr6037 ORF was constructed by two-step PCR using oligonucleotide pairs
ARSI1–ARSI8 and ARSI7–NIY3, and antibiotic resistance cassettes were in-
serted into an NcoI site upstream of the slr6037 ORF, generating pARSI8 (Sp
cassette) and pARSI9 (C.C1 cassette). For inactivation of grxA (ssr2061), a
1,269-bp DNA fragment was amplified using the oligonucleotide pair GRXA1–
GRXA4 and cloned into pGEMT, and the C.C1 cassette was inserted into an
SspI site located in the grxA ORF, generating pGRXA2. For inactivation of grxB
(slr1562), an 845-bp DNA fragment was amplified using the oligonucleotide pair
GRXB1–GRXB2 and cloned into pGEMT, and the Sp cassette was inserted
into an RsaI site located in the grxB ORF, generating pGRXB2. For inactivation
of grxC (slr1846), a 1,107-bp DNA fragment was amplified using the oligonucle-
otide pair GRXC1–GRXC2 and cloned into pGEMT, and the C.K1 cassette (8)
was inserted into a BstEII site, blunt ended with Klenow enzyme, and placed in
the grxC ORF, generating pGRXC2. Wild-type (WT) Synechocystis sp. strain
PCC 6803 or different mutants were transformed with the plasmids listed in
Table 1 to generate all the mutants used in this study.
Correct integration and complete segregation of the mutant strain were ana-
lyzed by Southern blotting. To this end, total DNA from cyanobacteria was
isolated as previously described (4). DNA was digested with appropriate en-
zymes, electrophoresed on 0.7% agarose gels in a Tris-borate-EDTA buffer
system (45), and subsequently transferred to nylon Z-probe membranes (Bio-
Rad). DNA probes were 32P labeled with a random-primer kit (Amersham
Biosciences) using [-32P]dCTP (3,000 Ci/mmol).
Cloning and expression of ArsCsyn, ArsI, GrxA, GrxB, and GrxC. Proteins
were expressed with either a carboxy-terminal (ArsCsyn and ArsI) or an amino-
terminal (GrxA, GrxB, and GrxC) six-histidine tag. The arsC gene was amplified
from cosmid cs0223 (provided by Kazusa DNA Research Institute) using oligo-
nucleotides ARSC3 and ARSC5, which introduced NdeI and XhoI restriction
sites, respectively. The DNA fragment obtained was digested with NdeI-XhoI
and cloned into NdeI-XhoI-digested pET24. The arsI gene was amplified using
oligonucleotides ArsI1 and ArsI3 (which introduces an XhoI restriction site) and
was cloned into NcoI-XhoI-digested pET24. The NcoI site is already included in
the genomic sequence of arsI. grxA was amplified using GRXA5 (which intro-
duces a BamHI restriction site) and GRXA4 from total genomic DNA. The
corresponding DNA fragment was digested with BamHI and cloned into
BamHI-digested pQE80, generating pGRXA4. grxB was amplified from total
genomic DNA using oligonucleotides GRXB3 and GRXB5, which introduced
BamHI and SalI restriction sites, respectively. The resulting DNA fragment was
digested with BamHI and SalI and was cloned into BamHI-SalI-digested pQE80,
generating pGRXB4. grxC was amplified using GRXC3 (which introduces a
BamHI restriction site) and GRXC2 from total genomic DNA. The resulting
DNA fragment was digested with BamHI and HindIII and was cloned into
BamHI-HindIII-digested pQE80, generating pGRXC4.
ArsCsyn and ArsI were produced in E. coli BL21, and GrxA, GrxB, and GrxC
in E. coli XL1-Blue, transformed with the plasmids described above. Cells were
grown at 37°C to an optical density at 600 nm of 0.5; 1 mM IPTG (isopropyl-
thio--D-galactopyranoside) was added; and the cultures were grown for 3 h at
30°C. The cells were harvested and frozen. Pellets were thawed on ice and
resuspended in 20 ml of 50 mM Tris HCl (pH 8.0)–0.5 M NaCl (buffer A) per g
(fresh weight). The cells were broken by sonication, and cell debris was removed
by centrifugation at 50,000  g for 20 min. The liquid supernatant was applied to
a 1-ml HiTrap chelating column (Amersham Biosciences) charged with NiSO4
and was subsequently equilibrated in buffer A. The column was first washed with
100 ml of buffer A and then with 50 ml of buffer A supplemented with 25 mM
imidazole, and adherent proteins were eluted by a 40-ml linear gradient from
0.025 to 0.5 M imidazole in buffer A. Imidazole and salts were removed by gel
TABLE 1. Strains used in this work
Strain Genotype Parental strain Mutated ORF(s) Plasmid used fortransformation Antibiotic resistance
WT Synechocystis sp. strain PCC 6803
SARS4 arsC::C.K1 WT slr0946 pARSC2 Km
SARS5 arsR::C.C1 WT sll1957 pARSR2 Cm
SARS6 arsI1::Sp WT sll5104 pARSI2 Sp
SARS7 arsI2::Sp WT slr6037 pARSI2 Sp
SARS8 arsI2::Sp WT slr6037 pARSI8 Sp
SARS9 arsI1::Sp arsI2::C.C1 SARS6 slr6037, sll5104 pARSI9 Sp Cm
SARS10 arsC::C.K1 arsI1::C.C1 SARS4 slr0946, sll5104 pARSI4 Km Cm
SARS11 arsC::C.K1 arsI2::Sp SARS4 slr0946, slr6037 pARSI8 Km Sp
SARS12 arsC::C.K1 arsI1::C.C1 arsI2::Sp SARS10 slr0946, slr6037, sll5104 pARSI8 Km Cm Sp
SGRXA grxA::C.C1 WT ssr2061 pGRXA2 Cm
SGRXB grxB::Sp WT slr1562 pGRXB2 Sp
SGRXC grxC::C.K1 WT slr1846 pGRXC2 Km
SGRXAB grxA::C.C1 grxB::Sp SGRXA ssr2061, slr1562 pGRXB2 Cm Sp
SGRXAC grxA::C.C1 grxC::C.K1 SGRXA ssr2061, slr1846 pGRXC2 Cm Km
SGRXBC grxB::Sp grxC::C.K1 SGRXB slr1562, slr1846 pGRXC2 Sp Km
SGRXABC grxA::C.C1 grxB::Sp grxC::C.K1 SGRXAB ssr2061, slr1562, slr1846 pGRX2C Cm Sp Km
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filtration using HiTrap desalting columns (Amersham Biosciences) run in 50 mM
Tris-HCl pH (8.0)–150 mM NaCl.
Arsenate reductase assay. Arsenate reductase activity was measured as de-
scribed previously in a coupled assay with GSH and glutathione reductase (19).
Assays for glutaredoxin Km determination were carried out in 50 mM Tris-HCl
(pH 7.5), 10 mM GSH, 50 mM Na2HAsO4, 1 U of yeast glutathione reductase
(Sigma), 5 M of ArsCsyn or 1 M of ArsI, and different amounts of glutare-
doxins. Activity was monitored spectrophotometrically at 340 nm and was cal-
culated using a ε of 6.22 mM for NADPH. We calculated kinetic parameters
using double-reciprocal plots.
ArsCsyn site-directed mutagenesis. The arsC gene was mutated by two over-
lapping PCR fragments introducing the desired changes using oligonucleotide
pairs ARSCmut1–ARSC3 and ARSCmut2–ARSC5 in the first PCR and
ARSC3–ARSC5 in the second. The PCR product was digested with NcoI and
XhoI and was then cloned into the NcoI-XhoI-digested vector pET24. The
mutant ArsCsyn protein was expressed and purified by the same procedure
described for wild-type ArsCsyn.
ArsCsyn-TrxA(C35S) interaction. Interaction assays were carried out by incu-
bating 10 g of WT or mutant ArsCsyn with 10 g of TrxA(C35S), prepared as
described in reference 20, in 50 mM Tris-HCl (pH 8.0) in the presence or
absence of 100 mM Na2HAsO4 at room temperature for 30 min. Reactions were
stopped by the addition of 1 volume of Laemmli buffer without reductant.
Samples were boiled for 5 min, and 1 g was used for Western blotting using
12% sodium dodecyl sulfate (SDS)–nonreducing polyacrylamide gel electro-
phoresis (PAGE) and anti-TrxA antibodies (35) at a 1:10,000 dilution.
RNA isolation and Northern blot analysis. Total RNA was isolated from 25-ml
samples of Synechocystis cultures at the mid-exponential phase (3 to 5 g chlo-
rophyll/ml). Extractions were performed by vortexing cells in the presence of
phenol:chloroform and acid-washed baked glass beads (diameter, 0.25 to 0.3
mm; Braun, Melsungen, Germany) as previously described (12) For Northern
blotting, 15 g of total RNA was loaded per lane, electrophoresed in 1.0%
agarose denaturing formaldehyde gels, and transferred to nylon membranes
(Hybond N-plus; Amersham Biosciences). Prehybridization, hybridization, and
washes were performed as described in the Amersham instruction manual.
Probes for Northern blot hybridization were synthesized by PCR using oligonu-
cleotide pairs ARSC1–ARSC2, ARSI3–ARSI4, GRXA250F–GRXA250F,
GrxB331F–GrxB331R, and GrxC295F–GrxC295R (see Table S1 in the supple-
mental material) for arsC, arsI, grxA, grxB, and grxC, respectively. As a control, in
all cases the filters were stripped and reprobed with a 580-bp HindIII-BamHI
probe from plasmid pAV1100 containing the constitutively expressed RNase P
RNA gene (rnpB) from Synechocystis sp. strain PCC 6803 (49). DNA probes were
32P labeled with a random-primer kit (Amersham Biosciences) using
[-32P]dCTP (3,000 Ci/mmol).
RESULTS
Identification and mutagenesis of two new additional arsen-
ate reductase genes. Sequence inspection of the four major
Synechocystis plasmids allowed us to identify two putative
genes (sll5104 and slr6037) encoding an arsenate reductase
related to that of E. coli (49% identity to E. coli ArsC) (15). We
designated these genes arsI1 and arsI2, respectively. The arsI
genes are almost identical at the nucleotide level (99% iden-
tity) and encode identical proteins, probably reflecting a recent
duplication event. They are located in a 2.5-kb region dupli-
cated between pSYSM and pSYSX that contains three addi-
tional ORFs: one encoding a putative cytidine deaminase
(sll5107 and slr6034), one small ORF encoding a protein with
an unknown function (ssr5106 and ssl6035), and the third ORF
encoding a ParA homolog (slr5105 and sll6036) (Fig. 1; note
that although this region is duplicated, its orientation is re-
versed). The arsI genes are expressed at very low levels, and
neither is regulated by the presence of arsenic in the medium
(Fig. 2) or by arsR (data not shown).
To investigate whether the presence of these additional ar-
senate reductases could explain the highly arsenate resistant
phenotype of a Synechocystis arsC mutant, strain SARS4 (pre-
viously named arsC::CK1 [23]) (Table 1), we carried out inser-
tional mutagenesis of the arsI1 and arsI2 genes. After trans-
formation of the WT strain or SARS4 with plasmid pARSI2 or
pARSI4, we obtained mutants with alterations in either arsI1
or arsI2 (66% arsI1 versus 33% arsI2). Subsequently, strains
with arsI1 or arsI2 inactivated (SARS6, SARS7, and SARS10)
were used to generate double or triple mutants using plasmids
with an insertion of a different antibiotic resistance cassette in
the other arsI gene. After several attempts, we still were unable
to obtain mutant strains with both arsI genes inactivated, since
the gene already inactivated was always partially or totally
replaced by the new allele, even if both antibiotics were used in
the selection step. In order to obtain double arsI mutants, we
constructed plasmids in which the arsI2 downstream flanking
region (not present in pSYSM [Fig. 1]) was included but the
entire arsI2 ORF was deleted (from 46 bp upstream to 45 bp
downstream of the arsI2 ORF) and a resistance cassette was
inserted 205 bp before the starting ATG of the arsI2 ORF
(pARSI8 and pARSI9). This target integration to pSYSX as an
arsI2 downstream flanking region, which is included in this
plasmid, is not found in pSYSM. Transformation of the WT
strain, SARS4, or SARS10 with plasmid pARSI8 and of
SARS6 with pARSI9 resulted in deletion of the arsI2 gene,
allowing us to study the role of each arsenate reductase in
arsenic resistance in Synechocystis sp. strain PCC 6803. Single
mutants of any of the arsI genes or double mutants of both arsI
genes, independently of the alleles (Fig. 3 and data not shown),
displayed the same resistance to the presence of arsenate as
the WT strain, probably due to the presence of ArsC (Fig. 3).
In contrast, inactivation of either of the two arsI genes in an
arsC::C.K1 background rendered the cells more sensitive to
arsenate in the medium (Fig. 3, strains SARS10 and SARS11).
We have previously studied arsenate toxicity in media with
reduced amounts of phosphate (23) (a condition that does not
affect the growth of any of the strains tested [Fig. 3]), since this
compound has a protective effect against arsenate toxicity,
probably affecting arsenate transport (37, 48) (Fig. 3). The
strain in which all genes encoding arsenate reductases are
inactivated (SARS12) was sensitive to arsenate even in the
presence of the standard phosphate concentration in BG11;
under the same conditions, none of the other strains were
affected (Fig. 3). This indicates that the arsI genes are essential
only in the absence of ArsCsyn and that both arsI genes are
active in arsenate resistance.
Biochemical characterization of ArsCsyn and ArsI. In order
to study both types of arsenate reductases, we overexpressed
and purified them by metal affinity chromatography. First we
confirmed that ArsCsyn presents GSH-dependent arsenate re-
ductase activity by using E. coli Grx1 as previously described
(19) (Fig. 4A). ArsI displays the same activity (Fig. 4A), as
predicted by its high similarity to E. coli ArsC and its conser-
vation of residues essential for arsenate reductase activity. Al-
though a biochemical characterization of ArsCsyn has been
published previously, that study was carried out using E. coli
Grx1, a heterologous electron donor (19). We aimed at char-
acterizing the biochemical properties of ArsCsyn by using its
physiological electron donor, and to that end we have used
Synechocystis glutaredoxins. Synechocystis sp. strain PCC 6803
contains three ORFs coding for glutaredoxin proteins: ssr2061,
slr1562, and slr1846 (16). The first two ORFs code for proteins
that belong to the bacterial dithiolic family, and we have des-
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ignated them GrxA and GrxB, respectively, while the third
ORF encodes a protein, here designated GrxC, that belongs to
the newly described monothiolic family (28, 41). We purified
these glutaredoxins fused to an amino-terminal histidine tag
and analyzed whether they were able to reduce ArsCsyn and
ArsI. We found that only the dithiolic glutaredoxins (GrxA and
GrxB) are able to reduce both arsenate reductases, while GrxC
is totally inactive with both reductases. In this regard, ArsI
showed a clear preference for GrxA, as reflected by a much
lower Km (60 nM for GrxA versus 1.3 M for GrxB), while
ArsCsyn seemed to be able to use both GrxA and GrxB with
almost the same efficiency, since it displayed similar Kms for
the two glutaredoxins (0.25 M and 0.994 M, respectively)
(Table 2). Since GrxA was the best reductant for both arsenate
reductases, we used it to determine kinetic parameters for
ArsCsyn and ArsI. Michaelis-Menten constants for arsenate
were 5.74 mM and 11 mM for ArsCsyn and ArsI, respectively.
The Vmax values were 2.81 and 1.3 mol/min, and the kcat
FIG. 1. ORF organization of arsI-containing regions in pSYSM and pSYSX. (A) Schematic representation of the pSYSM and pSYSX regions
containing arsI. The repeated sequence is shaded. Arrows indicate the direction of transcription. Filled arrows represent antibiotic resistance
cassettes, although for simplicity, only Sp is shown. (B) Schematic representation of the pSYSX arsI region present in strains SARSI8, SARSI9,
SARSI11, and SARS12. (C) Southern blot analysis of strains SARS4, SARS6, SARS7, SARS8, SARS9, SARS10, SARS11, and SARS12. Genomic
DNA was digested with NcoI and hybridized using the same DNA fragment indicated in panel A as a probe. The sizes of the hybridizing bands
are given on the right of the gels.
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values were 33.72 s1 and 79.2 s1, for ArsCsyn and ArsI,
respectively. These kinetic data for ArsCsyn and ArsI are in
agreement with those previously published for ArsCsyn using a
heterologous glutaredoxin (19) and for E. coli ArsC (21, 22)
(Table 2).
ArsCsyn belongs to a new family of arsenate reductases.
Amino acid sequence comparison showed that ArsCsyn is re-
lated to ArsC from S. aureus and B. subtilis (42% and 37%
identity, respectively). However, although they are clearly re-
lated, their biochemical properties are markedly different:
S. aureus ArsC uses thioredoxin as an electron donor, while
ArsCsyn uses GSH/glutaredoxin (Fig. 4A) (19, 26). The phylo-
genetic analysis suggests that the ArsCsyn type of arsenate
reductase is restricted to freshwater cyanobacteria and that no
related sequences are found in other organisms, while the
group of marine cyanobacteria contains only the glutaredoxin-
dependent type of arsenate reductase represented by E. coli ArsC
(see Table S2 in the supplemental material). ArsCsyn contains
three catalytic cysteines: C8, C80, and C82 (19), corresponding to
C10, C82, and C89 of S. aureus ArsC (Fig. 4B). These three
cysteines are essential for enzyme activity (3, 13, 24, 26) and are
strictly conserved in all cyanobacterial homologs. We speculated
that the difference in spacing between the second and the third
catalytic cysteines might explain why ArsCsyn uses GSH and glu-
taredoxin as electron donors instead of thioredoxin, since thiore-
doxin would be unable to reduce the disulfide bridge formed
between these two adjacent cysteines. In order to verify this hy-
pothesis, we constructed a modified arsC gene where the spacing
between active cysteines C80 and C82 was changed from 1 to 6
residues, as is the case for S. aureus ArsC (Fig. 4B). We mini-
mized the number of changes introduced into ArsCsyn to those
needed to change the spacing between the two catalytic cysteines,
which led to a model with a loop, instead of an -helix, in its
oxidized state (see Discussion). The mutated protein was ex-
pressed and purified and was found to display abnormally re-
duced mobility in SDS-PAGE (Fig. 4C). The mutated protein was
totally inactive in the coupled arsenate reductase assay using
either the thioredoxin or the GSH/glutaredoxin reducing system
(data not shown).
We also analyzed the capacity of ArsCsyn to interact with the
most abundant thioredoxin (TrxA) in Synechocystis sp. strain
PCC 6803 by using a modified version of TrxA in which the
second active-site cysteine has been replaced by Ser
[TrxA(C35S)], a mutation that allows the trapping of thiore-
doxin targets as mixed disulfides (20). We examined the abil-
ities of WT and mutant versions of ArsCsyn to interact with
TrxA(C35S) in vitro and asked if the presence of arsenate has
any effect on this interaction. To this end, we incubated ArsCsyn
for 15 min with or without 50 mM arsenate; then TrxA(C35S),
at an equimolar concentration, was added to the reaction mix-
ture, which was incubated for another 30 min. The reactions
FIG. 2. Northern blot analysis of the expression of the arsC and
arsI genes. Total RNA was isolated from mid-log-phase Synechocystis
cells grown in BG11C medium and exposed for 1 h either to 1 mM
sodium arsenite [As(III)] or to 10 mM sodium arsenate [As(V)]. Con-
trol cells were not exposed to added compounds. Fifteen micrograms
of total RNA was denatured, separated by electrophoresis on a 1%
agarose gel, blotted, and hybridized with probes for arsC and arsI. The
filters were stripped and rehybridized with an rnpB gene probe as a
control (see Materials and Methods).
FIG. 3. Phenotypic characterization of arsI mutants. The tolerance of WT Synechocystis sp. strain PCC 6803 and strains SARS4, SARS6,
SARS7, SARS8, SARS9, SARS10, SARS11, and SARS12 to arsenate was examined. Tenfold serial dilutions were spotted onto low-phosphate
BG11C plates ( phosphate) supplemented with 100 mM sodium arsenate [As(V)], BG11C plates ( phosphate) supplemented with 100 mM
sodium arsenate [As(V)], or low-phosphate BG11C plates or BG11C plates without additions. Plates were photographed after 10 days of growth.
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were stopped, and an aliquot was subjected to nonreducing
SDS-PAGE and analyzed by Western blotting using anti-TrxA
antibodies. While WT ArsCsyn was unable to interact with
TrxA(C35S) (Fig. 4D, lanes 3 and 4), the mutated version of
ArsCsyn was clearly able to form a mixed disulfide with
TrxA(C35S) (Fig. 4D, lanes 5 and 6).
Glutaredoxin specificity in vivo. To address whether the
glutaredoxins had any specificity in vivo, we studied glutare-
doxin expression in response to the presence of arsenate in the
FIG. 4. ArsC has a unique catalytic site. (A) Glutaredoxin-dependent arsenate reductase activities of ArsC and ArsI. Portions (25 g) of
purified ArsC and ArsI were assayed with 1 g of E. coli Grx1 following the couple reaction described in Materials and Methods. A control
assay without glutaredoxin addition was carried out. (B) Sequence alignment of ArsCsyn (WT), mutant ArsCsyn (mut), Alr1105 from
Anabaena sp. strain PCC 7120 (A.7120), and ArsC from Staphylococcus xylosus plasmid pSX267 or from S. aureus plasmid pI258. Identical
amino acids are asterisked; conservative changes are marked with “:” or . as defined by CLUSTAL X. Changes to ArsCsyn in the mutant are
underlined. (C) SDS-PAGE of purified mutant ArsCsyn (lane 1), WT ArsCsyn (lane 2), and TrxA(C35S) (lane 4). Lane 3, molecular mass
markers. (D) Western blot analysis of interaction experiment between ArsCsyn and TrxA(C35S). Proteins were incubated as described in
Materials and Methods. Lanes 1 and 2, reaction mixtures containing TrxA(C35S); lanes 3 and 4, reaction mixtures containing TrxA(C35S)
and WT ArsCsyn; lanes 5 and 6, reaction mixtures containing TrxA(C35S) and mutant ArsCsyn. Proteins were incubated in the presence of
100 mM Na2HAsO4 (lanes 1, 3, and 5) or in the absence of Na2HAsO4 (lanes 2, 4, and 6). The membrane was incubated with anti-TrxA
antibodies as described in Materials and Methods.
TABLE 2. Catalytic properties of ArsCsyn and ArsI
Arsenate
reductase
Km (M) Kinetic parameter determined with GrxA






ArsC 0.25 0.994 5.74 2.81 33.72
ArsI 0.063 1.369 11 1.32 79.2
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medium. Total RNAs from mid-exponential-phase growing
cells treated with 100 mM arsenate for 0.5, 1, and 2 h were
analyzed by Northern blotting using probes against the grxA,
grxB and grxC genes. While the levels of grxA and grxB tran-
scripts did not change significantly after arsenate addition,
even in the SGRXB or SGRXA mutant strain, respectively,
grxC showed induction in its mRNA (Fig. 5).
In order to further analyze the in vivo specificities of different
glutaredoxins, we constructed single, double, and triple mutant
strains with inactivated glutaredoxin genes. All mutants were vi-
able, and their growth rates were comparable to those of the WT
strain both in the presence and in the absence of phosphate (Fig.
6 and our unpublished results). However, analysis of their phe-
notypes in the presence of arsenate indicated that all strains
carrying an insertion in the grxA gene were less resistant to the
presence of arsenate than the WT strain (Fig. 6). Further inacti-
vation of the grxB or grxC gene had no effect on arsenate resis-
tance, indicating that GrxA is the main electron donor for both
ArsCsyn and ArsI in vivo. These results are in agreement with our
in vitro data, in which ArsI and ArsCsyn showed strong and mod-
erate specificities for GrxA, respectively.
DISCUSSION
Here we describe the arsenate-reducing system in Synecho-
cystis sp. strain PCC 6803, which consists of two different ar-
FIG. 5. Analysis of the expression of glutaredoxin genes in response to arsenate. (A) Northern blot analysis of the expression of the grxA, grxB,
and grxC genes. Total RNA was isolated from mid-log-phase Synechocystis cells grown in BG11C medium and was exposed to 100 mM sodium
arsenate for 0.5, 1, and 2 h. Control cells were not exposed. Fifteen micrograms of total RNA was denatured, separated by electrophoresis on a
1% agarose gel, blotted, and hybridized with probes for the grxA, grxB, and grxC genes. The filters were stripped and rehybridized with an rnpB
gene probe as the control (see Materials and Methods). (B and C) Northern blot analysis of the expression of grxB in strain SGRXA (B) and of
grxA in strain SGRXB (C) after arsenate exposure as described for panel A.
FIG. 6. Phenotypic characterization of the grx mutants. The tolerance of WT Synechocystis sp. strain PCC 6803 and strains SGRXA, SGRXB,
SGRXC, SGRXAB, SGRXAC, SGRXBC, and SGRXABC was tested. Tenfold serial dilutions were spotted onto low-phosphate BG11C plates
supplemented with 100 mM sodium arsenate [As(V)], low-phosphate BG11C plates ( phosphate), or BG11C plates. Plates were photographed
after 10 days of growth.
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senate reductases and implies the GSH/glutaredoxin system as
an electron donor. The presence of two different arsenate
reductases has also been reported for other bacterial strains by
genome analysis (5), but no in vivo experimental data have
been reported so far. Although the main resistance determi-
nant in Synechocystis sp. strain PCC 6803 involves the highly
inducible ArsCsyn (23), ArsI is here shown to play a role in its
absence. This enzyme could allow cells to tolerate small
amounts of arsenate, because its gene is expressed at low and
constitutive levels (Fig. 2). The fact that the differences in
phenotype between SARS10 and SARS11 (double mutants
with mutations of arsC and arsI), on the one hand, and
SARS12 (triple mutant with all arsenate reductase genes inac-
tivated), on the other, are observed only in media devoid of
phosphate probably reflects the entry into the cells of small
amounts of As(V), which are reduced by ArsI in strains
SARS4, SARS10, and SARS11.
Three families of arsenate reductases have been described to
date (25). Here we show that ArsCSyn, although related to
thioredoxin-dependent arsenate reductases, can be considered
a member of a new arsenate reductase family, since it clusters
together with sequences from other cyanobacteria, forming an
independent branch in phylogenetic trees (Fig. 7). The branch
that includes ArsCSyn has probably shifted from a thioredoxin-
dependent to a GSH-dependent reduction mechanism, and the
signature for this can be found in the C80–C82 pair of cysteines
(Fig. 4B). The arsenate reduction mechanism in the B. subtilis
and S. aureus ArsC enzymes is well described and involves a
disulfide cascade leading to conformational changes in the
-helix containing the reactive cysteines C82 and C89 (3, 24–
27). These cysteines are present in an -helix that is buried in
the ArsC structure, and oxidation of these cysteines to a disul-
fide bridge leads to a change from an -helix to a loop con-
formation. This structural reorganization exposes the disulfide
bridge and allows it to be reduced by thioredoxin (3, 13, 24,
26). The change in the spacing between these two cysteines in
ArsCsyn may explain why this protein is reduced by GSH but
not by thioredoxin. Two reasons can be argued. The first is that
a disulfide bridge between C80 and C82 probably would not
cause a conformational switch from an -helix to a loop con-
formation, because these cysteines are closely situated and will
not disturb the -helix. The second reason is that the spacing
is not adequate for thioredoxin interaction. The site-directed
mutagenesis of ArsCsyn supports the second explanation, al-
though modeling of WT and mutant ArsCsyn enzymes using
the SWISS-MODEL server with the sole constraint that the
C80 and C82 cysteines form a disulfide bridge results in a
model with an -helix in the WT and a loop in the mutant
(data not shown). Thus, a combination of both effects can be
claimed to explain the difference in reduction mechanisms
between S. aureus ArsC and ArsCsyn. Although a change in the
spacing between the cysteines is essential for thioredoxin in-
teraction (Fig. 4) and probably also for the conformational
change induced upon oxidation of the cysteines, changes other
than those introduced in this work may be needed to obtain
thioredoxin-dependent arsenate reduction activity, since there
are other residues conserved in S. aureus ArsC that are not
conserved in ArsCsyn. The change from a thioredoxin- to a
GSH-dependent mechanism in cyanobacterial arsenate reduc-
tase could be due to an easier availability of GSH than of
reduced thioredoxin. In this regard, the more abundant thiore-
doxin (TrxA) is essential in Synechocystis and in other cya-
nobacteria (11, 33, 34), probably indicating its main role in
regulating cell metabolism. Furthermore, other thioredoxins
FIG. 7. Phylogenetic analysis of ArsCsyn. Shown is a neighbor-joining
tree of full-length amino acid sequences of the following arsenate reduc-
tases (sequences are from the ENTREZ protein database): ArsCSyn (Syn-
echocystis), Alr1105 from Anabaena sp. strain PCC 7120 (A.7120; acces-
sion no. NP_485148), Ava 3712 from Anabaena variabilis (ZP_00159236),
Glr0004 from Gloeobacter violaceus (NP_922950.1), and ArsC enzymes
from Nostoc punctiforme (ZP_00108511), Crocosphaera watsonii WH 8501
(ZP_00349942), Lyngbya sp. strain PCC 8106 (ZP_01620002), Synecho-
coccus sp. strain JA-2-3B	a (Syn_JA-2-3B; YP_478568), Acaryochloris ma-
rina MBIC11017 (YP_001514958), Synechococcus sp. strain PCC 7002
(S.PCC7002; YP_001733851), Microcystis aeruginosa NIES-843
(YP_001655268), Cyanothece sp. strain ATCC 51142 (YP_001804412),
Bacillus subtilis (BAA12434), Staphylococcus xylosus plasmid pSX267
(Q0125), and S. aureus plasmid pI258 (P30330). Low-molecular-weight
phosphatases are Wzb from E. coli (ECU38473), PtpA from Streptomyces
coelicolor A3 (NP_628106), Ptp from Acintobacter johnsonii (CAA75430),
and YopH from Yersinia pseudotuberculosis (P08538). YopH was used as
the outgroup. The scale bar corresponds to 0.1 estimated amino acid
substitution per site. Bootstrap values for 1,000 permutations are shown.
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present in Synechocystis are expressed at lower levels and do
not respond to the presence of arsenate in the growth medium
(our unpublished observations). This is also supported by the
fact that all cyanobacterial arsenate reductases use GSH as a
reducing system (since they are homologs of ArsCsyn or E. coli
ArsC [see Table S2 in the supplemental material), except for
Synechococcus sp. strain JA-3-3Ab, which contains a gene cod-
ing for an ArsC protein of the S. aureus family (Fig. 7).
Interestingly, inactivation of all glutaredoxin genes does not
seem to affect the growth of Synechocystis sp. strain PCC 6803.
In most organisms, inactivation of all glutaredoxin genes is not
possible (7, 9). Recently it has been reported that GrxA inac-
tivation impairs H2O2 resistance in Synechocystis, that GrxA is
reduced by a thioredoxin reductase, and that reduced GrxA is
able to reduce GrxB (18). In addition, these investigators iden-
tified several putative targets that overlap with those of the
thioredoxin system in Synechocystis. These data suggest that
the two systems have redundant roles and that in the absence
of the glutaredoxin system, thioredoxins can reduce some of its
targets. Particularly striking is the lack of a clear phenotype of
the SGRXC mutant, since all homologs of grxC either are
essential or exhibit a drastic phenotype (2, 9, 41, 51). Synecho-
cystis GrxC has been shown to contain an iron-sulfur group
(38), like all other monothiolic glutaredoxins (9, 42), and can
partially complement the grx5 mutation in Saccharomyces cer-
evisiae (28), suggesting that GrxC is involved in iron-sulfur
assembly, as are plant and yeast monothiolic glutaredoxins (2,
42). Monothiolic glutaredoxin has been proposed to be a scaf-
fold, storage, or regulatory protein during Fe-S cluster assem-
bly in plant chloroplasts (2). Two Fe-S cluster assembly path-
ways, Suf and Isc, have been described for cyanobacteria (1, 14,
29, 50). The Suf system is involved in Fe-S cluster assembly for
photosystem I (with the help of a NifU like protein), while the
role of the Isc system is less well characterized. Further exper-
iments are required to clarify if Synechocystis GrxC has roles
similar to those of its plant homologs in Fe-S cluster assembly
and to determine its relation to the Suf and Isc pathways.
Our in vivo experiments demonstrate that GrxA has a cen-
tral role in arsenate reduction, since all strains lacking GrxA
are less tolerant of the presence of arsenate in the medium
than strains with GrxA. This phenotype is not due to a low
level of expression of the gshB gene, encoding GSH synthetase,
which is just downstream of the grxA gene and forms an operon
with it (our unpublished observations). Moreover, SGRXA
and WT strains contain the same levels of GSH (data not
shown). Our results indicate that at least in Synechocystis sp.
strain PCC 6803, and for ArsCSyn, there is a specific depen-
dence on GrxA as an electron donor, and GrxB cannot com-
pensate for the lack of GrxA in vivo. This is further supported
by the lack of induction of the grxB or grxA gene in strain
SGRXA or SGRXB, respectively, in response to the presence
of arsenate (Fig. 5B and C). These data also contrast with data
reported on arsenic resistance in E. coli, where resistance to
arsenate was not affected in any single glutaredoxin mutant or
in a triple mutant with all dithiolic glutaredoxin genes inter-
rupted, suggesting that there is another reductant for E. coli
ArsC (46). The strong specificity of ArsCsyn for GrxA in vivo
contrasts with the much smaller differences observed between
the specificities for GrxA and GrxB in vitro. Two reasons might
explain this apparent discrepancy. First, GrxA protein may be
much more abundant than GrxB. Second, the compartmental-
ization or spatial localization of GrxB may be different from
that of ArsCsyn. Further experiments will be required to inves-
tigate these possibilities.
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